Researchers have been excited about this new drug, a groundbreaking dual treatment showing remarkable results in initial trials for weight loss . It works by targeting both pathways : GLP-1 and GIP, https://abelelwt889355.timeblog.net/76663549/this-new-prospect-for-size-reduction